216 related articles for article (PubMed ID: 37284490)
21. Acceptability of multiple modalities of pre-exposure prophylaxis (PrEP) among female sex workers in Tanzania: a mixed-methods study.
Beckham SW; Mantsios A; Galai N; Likindikoki S; Mbwambo J; Davis W; Kerrigan D
BMJ Open; 2022 Aug; 12(8):e058611. PubMed ID: 35977762
[TBL] [Abstract][Full Text] [Related]
22. Inadvertent pregnancies in oral contraceptive users.
Kovacs GT; Riddoch G; Duncombe P; Welberry L; Chick P; Weisberg E; Leavesley GM; Baker HW
Med J Aust; 1989 May; 150(10):549-51. PubMed ID: 2716563
[TBL] [Abstract][Full Text] [Related]
23. Missed hormonal contraceptives: new recommendations.
Guilbert E; Black A; Dunn S; Senikas V; ;
J Obstet Gynaecol Can; 2008 Nov; 30(11):1050-1062. PubMed ID: 19126288
[TBL] [Abstract][Full Text] [Related]
24. A qualitative exploration to understand barriers and facilitators to daily oral PrEP uptake and sustained adherence among HIV-negative women planning for or with pregnancy in rural Southwestern Uganda.
Atukunda EC; Owembabazi M; Pratt MC; Psaros C; Muyindike W; Chitneni P; Bwana MB; Bangsberg D; Haberer JE; Marrazzo J; Matthews LT
J Int AIDS Soc; 2022 Mar; 25(3):e25894. PubMed ID: 35324081
[TBL] [Abstract][Full Text] [Related]
25. Why do inadvertent pregnancies occur in oral contraceptive users? Effectiveness of oral contraceptive regimens and interfering factors.
Fraser IS; Jansen RP
Contraception; 1983 Jun; 27(6):531-51. PubMed ID: 6413129
[TBL] [Abstract][Full Text] [Related]
26. Patient understanding of oral contraceptive pill instructions related to missed pills: a systematic review.
Zapata LB; Steenland MW; Brahmi D; Marchbanks PA; Curtis KM
Contraception; 2013 May; 87(5):674-84. PubMed ID: 23040136
[TBL] [Abstract][Full Text] [Related]
27. Impact of the October 1995 pill scare in Grampian.
Flett G; Gurney E; McKessock L; Reid J
Br J Fam Plann; 1998 Apr; 24(1):18-20. PubMed ID: 9719702
[TBL] [Abstract][Full Text] [Related]
28. Contraceptive choices for adolescents.
Woods ER
Pediatr Ann; 1991 Jun; 20(6):313-21. PubMed ID: 1861894
[TBL] [Abstract][Full Text] [Related]
29. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
[TBL] [Abstract][Full Text] [Related]
30. Comparative study on the efficacy, acceptability, and side effects of a contraceptive pill administered by the oral and the vaginal route: an international multicenter clinical trial.
Coutinho EM; Mascarenhas I; de Acosta OM; Flores JG; Gu ZP; Ladipo OA; Adekunle AO; Otolorin EO; Shaaban MM; Abul Oyoon M
Clin Pharmacol Ther; 1993 Nov; 54(5):540-5. PubMed ID: 8222497
[TBL] [Abstract][Full Text] [Related]
31. Integration of HIV Prevention With Sexual and Reproductive Health Services: Evidence for Contraceptive Options and HIV Outcomes Study Experience of Integrating Oral Pre-exposure HIV Prophylaxis in Family Planning Services in Lusaka, Zambia.
Kasaro MP; Sindano N; Chinyama M; Mudenda M; Chilaisha F; Price JT; Chileshe M
Front Reprod Health; 2021; 3():684717. PubMed ID: 36304051
[TBL] [Abstract][Full Text] [Related]
32. Lessons from reproductive health to inform multipurpose prevention technologies: don't reinvent the wheel.
Brady M; Manning J
Antiviral Res; 2013 Dec; 100 Suppl():S25-31. PubMed ID: 24188700
[TBL] [Abstract][Full Text] [Related]
33. Understanding the Acceptability of Subdermal Implants as a Possible New HIV Prevention Method: Multi-Stage Mixed Methods Study.
Rael CT; Lentz C; Carballo-Diéguez A; Giguere R; Dolezal C; Feller D; D'Aquila RT; Hope TJ
J Med Internet Res; 2020 Jul; 22(7):e16904. PubMed ID: 32348277
[TBL] [Abstract][Full Text] [Related]
34. Key barriers and enablers associated with uptake and continuation of oral pre-exposure prophylaxis (PrEP) in the public sector in Zimbabwe: Qualitative perspectives of general population clients at high risk for HIV.
Gombe MM; Cakouros BE; Ncube G; Zwangobani N; Mareke P; Mkwamba A; Prescott MR; Bhatasara T; Murwira M; Mangwiro AZ; Prust ML
PLoS One; 2020; 15(1):e0227632. PubMed ID: 31931514
[TBL] [Abstract][Full Text] [Related]
35. Synthesis of end-user research to inform future multipurpose prevention technologies in sub-Saharan Africa: a scoping review.
Bhushan NL; Ridgeway K; Luecke EH; Palanee-Phillips T; Montgomery ET; Minnis AM
Front Reprod Health; 2023; 5():1156864. PubMed ID: 37325244
[TBL] [Abstract][Full Text] [Related]
36. HIV prevention: better choice for better coverage.
Bekker LG; Pike C; Hillier SL
J Int AIDS Soc; 2022 Jan; 25(1):e25872. PubMed ID: 35030296
[TBL] [Abstract][Full Text] [Related]
37. Offering extended use of the combined contraceptive pill: a survey of specialist family planning services.
Sauer U; Mann S; Brima N; Stephenson J
Int J Womens Health; 2013; 5():613-7. PubMed ID: 24109198
[TBL] [Abstract][Full Text] [Related]
38. Quadriphasic versus monophasic oral contraceptives for contraception.
Van Vliet HA; Raps M; Lopez LM; Helmerhorst FM
Cochrane Database Syst Rev; 2011 Nov; (11):CD009038. PubMed ID: 22071862
[TBL] [Abstract][Full Text] [Related]
39. Brief Report: Impact of PrEP Training for Family Planning Providers on HIV Prevention Counseling and Patient Interest in PrEP in Atlanta, Georgia.
Sales JM; Cwiak C; Haddad LB; Phillips A; Powell L; Tamler I; Sheth AN
J Acquir Immune Defic Syndr; 2019 Aug; 81(4):414-418. PubMed ID: 30985558
[TBL] [Abstract][Full Text] [Related]
40. Pre-exposure prophylaxis for HIV-1 prevention does not diminish the pregnancy prevention effectiveness of hormonal contraception.
Murnane PM; Heffron R; Ronald A; Bukusi EA; Donnell D; Mugo NR; Were E; Mujugira A; Kiarie J; Celum C; Baeten JM;
AIDS; 2014 Jul; 28(12):1825-30. PubMed ID: 24785951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
